Vivo Surgical has been recognised as one of the Top 4 Grand Prize Finalists in the MedTech Innovator 5th Annual Asia Pacific Competition. Over 400 companies applied to be part of the 2023 Asia Pacific Accelerator Cohort, from which 24 companies were shortlisted to partake the 4-month accelerator program.
The grand finals took place on 5th December 2023 at the Suntec Singapore Convention & Exhibition Centre, where our CEO Dr Kevin Koh presented our cutting-edge ERES™ Endoscope Robot for advanced endoscopic surgeries of the gastrointestinal tract
In addition to the finalist award, Vivo Surgical was also awarded a US$ 25,000 Cambridge Consultants Product Development Prize.
Since our inclusion in the initial cohort of 20 companies, the past few months of brainstorming and discussions with our wonderful mentors from Johnson & Johnson MedTech (Ashley Wittorf) and Cambridge Consultants (Yan Lin Lye, Sylvain Jamais) have been instrumental in guiding the go-to-market strategies and technical development of our ERES™ endoscope robot. We remain most grateful for their input and guidance.
We look forward to working closely with industry stakeholders as we push towards pivotal clinical trials and commercial development of our ERES™ endoscopic robot.
Comments